Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Longterm decrease in the CD57 lymphocyte subset in a patient with chronic Lyme disease.

Raphael B Stricker1, Joseph Burrascano, Edward Winger

  • 1California Pacific Medical Center, 450 Sutter Street, Suite 1504, San Francisco, CA 94108, USA. rstricker@usmamed.com

Annals of Agricultural and Environmental Medicine : AAEM
|June 29, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimizing Exclusion Criteria for Clinical Trials of Persistent Lyme Disease Using Real-World Data.

Healthcare (Basel, Switzerland)·2025
Same author

Does Biological Sex Matter in Lyme Disease? The Need for Sex-Disaggregated Data in Persistent Illness.

International journal of general medicine·2023
Same author

Role of hydroxychloroquine in multidrug treatment of COVID-19.

Reviews in cardiovascular medicine·2021
Same author

Hydroxychloroquine Pre-Exposure Prophylaxis for COVID-19 in Healthcare Workers from India: A Meta-Analysis.

Journal of infection and public health·2021
Same author

Dermatological and Genital Manifestations of Lyme Disease Including Morgellons Disease.

Clinical, cosmetic and investigational dermatology·2021
Same author

Pre-Exposure Prophylaxis for COVID-19 in Pregnant Women.

International journal of general medicine·2021

Chronic Lyme disease patients often show decreased CD57 lymphocytes. This study documents this immune abnormality for 10 years in one patient, highlighting CD57 as a marker for long-term Borrelia burgdorferi infection.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Microbiology

Background:

  • Lyme disease is a tickborne illness caused by Borrelia burgdorferi.
  • Previous research indicated reduced CD57 lymphocyte subsets in chronic Lyme disease patients.

Observation:

  • A patient with chronic, relapsing-remitting Lyme disease symptoms was monitored.
  • This patient exhibited decreased CD57 lymphocyte levels for a decade.

Findings:

  • The observed 10-year duration of decreased CD57 lymphocytes is the longest immunologic abnormality documented in chronic Lyme disease.
  • CD57 lymphocyte subset levels appear to correlate with long-term Borrelia burgdorferi infection.

Implications:

  • CD57 lymphocyte counts may serve as a valuable biomarker for assessing the duration and persistence of Lyme disease infection.

Related Experiment Videos

  • Further research into immunologic markers could improve chronic Lyme disease diagnosis and management.